Nan Fung Life Sciences Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 14

Professionals

  • Investments
  • 16

  • Portfolio
  • 13

  • Exits
  • 3

Exits

Nan Fung Life Sciences General Information

Company Description

Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences. The company does direct investments via Pivotal bioVenture Partners funds and fund investments covering full spectrum of the industry (including therapeutics, medical devices and diagnostics) and across different development stages. The firm has presence in both US and Greater China. It was founded in 2017 and is based in Hong Kong.

Business Details

Year Founded
2017
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
PE/Buyout
Corporate Office
  • 23rd Floor, Nan Fung Tower
  • 88 Connaught Road C, Central
  • Hong Kong
  • Hong Kong

Nan Fung Life Sciences Investments (16)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Arkuda Therapeutics 25-Jan-2022 Early Stage VC Drug Discovery Generating Revenue
Ablaze Pharmaceuticals 29-Nov-2021 Drug Discovery Startup
HotSpot Therapeutics 16-Nov-2021 Drug Discovery Clinical Trials - Phase 1
Fountain Therapeutics 15-Nov-2021 Drug Discovery Generating Revenue
Addition Therapeutics 24-Sep-2021 Biotechnology Startup
Obsidian Therapeutics 09-Sep-2021 Drug Discovery Clinical Trials - Phase 2
Encodia 24-Jan-2021 Biotechnology Generating Revenue
Selonterra 01-Dec-2020 Drug Discovery Pre-Clinical Trials
Avalyn Pharma 24-Apr-2020 Later Stage VC Drug Discovery Clinical Trials - Phase 2
Akouos 03-Mar-2020 Early Stage VC Drug Discovery Generating Revenue
You’re viewing 10 of 16 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nan Fung Life Sciences Exits (3)

Company Name Exit Date Exit Type Exit Size
Anthos Therapeutics 03-Apr-2025 Merger/Acquisition
Navitor Pharmaceuticals 25-Oct-2024
Akouos 01-Dec-2022
To view Nan Fung Life Sciences’s complete exits history, request access »

Nan Fung Life Sciences Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Nan Fung Life Sciences FAQs

  • What is Nan Fung Life Sciences?

    Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences.

  • When was Nan Fung Life Sciences founded?

    Nan Fung Life Sciences was founded in 2017.

  • Where is Nan Fung Life Sciences headquartered?

    Nan Fung Life Sciences is headquartered in Hong Kong, Hong Kong.

  • How many investments has Nan Fung Life Sciences made?

    Nan Fung Life Sciences has made 16 investments.

  • What has Nan Fung Life Sciences invested in?

    Nan Fung Life Sciences has made numerous investments in companies like Arkuda Therapeutics, Ablaze Pharmaceuticals, and HotSpot Therapeutics within the Drug Discovery industry.

  • What has Nan Fung Life Sciences invested in recently?

    Nan Fung Life Sciences's latest investment was on 25-Jan-2022 in Arkuda Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »